Document is current
Any future updates will be listed below
-
Authors
Tanaka, Atsushi
Shimabukuro, Michio
Teragawa, Hiroki
Yoshida, Hisako
Okada, Yosuke
Takamura, Toshinari
Taguchi, Isao
Toyoda, Shigeru
Tomiyama, Hirofumi
Ueda, Shinichiro
Higashi, Yukihito
Node, Koichi
,
Ako, Junya
Amano, Hirohisa
Hisauchi, Itaru
Ikehara, Yumi
Jinnouchi, Hideaki
Kawano, Yoshiyuki
Kimura, Kazuo
Kurozumi, Akira
Kusumoto, Takaaki
Machii, Noritaka
Maruhashi, Tatsuya
Matsuzawa, Yasushi
Misu, Hirofumi
Narisawa, Manabu
Ota, Tsuguhito
Oyama, Jun-ichi
Sakuma, Masashi
Shiina, Kazuki
Shima, Kosuke R.
Sugiyama, Seigo
Suzuki, Kunihiro
Takahashi, Naohiko
Takemoto, Yasuhiko
Takeshita, Yumie
Tamaki, Hiroshi
Tanaka, Kenichi
Tamura, Akira
Torimoto, Keiichi
Yamaoka-Tojo, Minako
Uehara, Hiroki
Uemura, Fumi
Yamakawa, Ken
Yufu, Kunio
- License Information
-
More Information
Article History
Received: 25 January 2024
Revised: 18 April 2024
Accepted: 21 April 2024
First Online: 24 May 2024
Compliance with ethical standards
:
: A.T. received honoraria from Nippon Boehringer Ingelheim and Mochida and research funding from GlaxoSmithKline, Takeda, Bristol-Myers Squibb, and Novo Nordisk Pharma. M.S. received honorarium and an endowed chair from Boehringer Ingelheim. H.Te. received lecture fees from Bayer, Boehringer Ingelheim, Daiichi Sankyo, Kowa, Takeda, Mitsubishi Tanabe, and Sanwa Kagaku Kenkyusyo. Y.O. received lecture fees from MSD, Mitsubishi Tanabe, Novo Nordisk Pharma, Eli Lilly Japan, Novartis Pharma, Kissei, Kowa, and Sumitomo Pharma and research fund from Kissei. T.T. received lecture fees from Kowa and Taisho and research grants from Kowa and Taisho. S.T. received honoraria from Daiichi Sankyo, AstraZeneca, Bayer, Nippon Boehringer Ingelheim, TSUMURA, and Novo Nordisk Pharma. Y.H. received grants from Mitsubishi Tanabe Pharma Corporation, Teijin Pharma Limited, Boehringer Ingelheim GmbH, Merck Sharp & Dohme Corporation, Sanofi Kabushiki Kaisya, AstraZeneca Kabushiki Kaisya, Kyowa Hakko Kirin Company Limited, Takeda Pharmaceutical Company Limited, Astellas Pharma Incorporated, Daiichi Sankyo Company Limited, Mochida Pharmaceutical Company Limited, Nihon Kohden Corporation, Shionogi Company Limited, Nippon Sigmax Company Limited, Sanwa Kagaku Kenkyusho Company Limited, Unex Corporation, and Kao Corporation, and honoraria from Radiometer Limited, Omron Corporation, Sumitomo Dainippon Pharma Company Limited, Otsuka Pharmaceutical Company Limited, Torii Pharmaceutical Company Limited, Kowa Company Limited, Fujiyakuhin Company Limited, Amgen Astellas BioPharma Kabushiki Kaisya, Nippon Shinyaku Company Limited, Itamar Medical Limited, Bayer Holding Limited, Eli Lilly Kabushiki Kaisya, and Ono Pharmaceutical Company Limited. K.N. received honoraria from AstraZeneca, Bayer Yakuhin, Nippon Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly Japan, Kowa, Mitsubishi Tanabe Pharma, MSD, Novartis Pharma, Novo Nordisk Pharma, Ono Pharmaceutical, Otsuka, and Takeda Pharmaceutical, research grants from Asahi Kasei, Astellas, Nippon Boehringer Ingelheim, Fuji Yakuhin, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Novartis Pharma, and Teijin Pharma, and scholarship from Bayer Yakuhin, Medtronic, and Teijin Pharma. Other authors declare no competing interests.
